Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(10):1005–20.

Article  CAS  PubMed  Google Scholar 

Sundar R, Nakayama I, Markar SR, Shitara K, van Laarhoven HWM, Janjigian YY, et al. Gastric cancer. Lancet. 2025;405(10494):2087–102.

Article  CAS  PubMed  Google Scholar 

Mamun TI, Younus S, Rahman MH. Gastric cancer-Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: An updated review. Cancer Treat Res Commun. 2024;41:100845.

PubMed  Google Scholar 

Iyer P, Moslim M, Farma JM, Denlinger CS. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl Gastroenterol Hepatol. 2020;5:52.

Article  PubMed  PubMed Central  Google Scholar 

Tanaka H, Yoshii M, Imai T, Tamura T, Toyokawa T, Muguruma K, et al. Clinical significance of coexisting histological diffuse type in stage II/III gastric cancer. Mol Clin Oncol. 2021;15(5):234.

Article  PubMed  PubMed Central  Google Scholar 

Lee JH, Chang KK, Yoon C, Tang LH, Strong VE, Yoon SS. Lauren Histologic Type Is the Most Important Factor Associated With Pattern of Recurrence Following Resection of Gastric Adenocarcinoma. Ann Surg. 2018;267(1):105–13.

Article  PubMed  PubMed Central  Google Scholar 

Wachtel MS, Zhang Y, Chiriva-Internati M, Frezza EE. Different regression equations relate age to the incidence of Lauren types 1 and 2 stomach cancer in the SEER database: these equations are unaffected by sex or race. BMC Cancer. 2006;6(1):65.

Article  PubMed  PubMed Central  Google Scholar 

Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev. 2009;18(7):1945–52.

Article  PubMed  PubMed Central  Google Scholar 

Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020;39(4):1179–203.

Article  PubMed  PubMed Central  Google Scholar 

Heberer G, Teichmann RK, Krämling HJ, Günther B. Results of gastric resection for carcinoma of the stomach: the European experience. World J Surg. 1988;12(3):374–81.

Article  CAS  PubMed  Google Scholar 

Moslim MA, Handorf E, Reddy SS, Greco SH, Farma JM. Partial gastrectomy is associated with improved overall survival in signet-ring cell gastric cancer. J Surg Res. 2021;266:27–34.

Article  PubMed  Google Scholar 

Boubaddi M, Teixeira Farinha H, Lambert C, Pereira B, Piessen G, Gualtierotti M, et al. Total Versus Subtotal Gastrectomy for Distal Gastric Poorly Cohesive Carcinoma. Ann Surg Oncol. 2024;31(2):744–52.

Article  PubMed  Google Scholar 

Aytaç E, Aslan F, Çicek B, Erdamar S, Gürses B, Güven K, et al. Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group. Turk J Gastroenterol. 2019;30(7):584–98.

Article  PubMed  PubMed Central  Google Scholar 

Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019;393(10184):1948–57.

Article  PubMed  Google Scholar 

Möhring C, Mańczak A, Timotheou A, Sadeghlar F, Zhou T, Mahn R, et al. Perioperative therapy with FLOT4 significantly increases survival in patients with gastroesophageal and gastric cancer in a large real-world cohort. Int J Cancer. 2023;153(3):609–22.

Article  PubMed  Google Scholar 

Schütte K, Schulz C, Middelberg-Bisping K. Impact of gastric cancer treatment on quality of life of patients. Best Pract Res Clin Gastroenterol. 2021;50–51:101727.

Article  PubMed  Google Scholar 

Durán Giménez-Rico H, Diéguez Aguirre L, Ríos Pérez L, Cardinal-Fernández P, Caruso R, Ferri V, et al. Comparative study between total and subtotal gastrectomy for distal gastric cancer: meta-analysis of prospective and retrospective studies. Cir Esp (Engl Ed). 2020;98(10):582–90.

Article  PubMed  Google Scholar 

de Jongh C, van der Veen A, Brosens LAA, Nieuwenhuijzen GAP, Stoot J, Ruurda JP, et al. Distal versus total D2-gastrectomy for gastric cancer: a secondary analysis of surgical and oncological outcomes including quality of life in the multicenter randomized LOGICA-Trial. J Gastrointest Surg. 2023;27(9):1812–24.

Article  PubMed  PubMed Central  Google Scholar 

SPACE-FLOT Investigators. Pathological response guides adjuvant 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy in surgically resected gastro-oesophageal cancer (SPACE-FLOT): international cohort study. Br J Surg. 2025;112(4):znaf056

World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4.

Article  Google Scholar 

Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182–8.

Article  PubMed  Google Scholar 

Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition). Gastric Cancer. 2023;26(1):1–25.

Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.

Article  CAS  PubMed  Google Scholar 

Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.

Article  CAS  PubMed  Google Scholar 

Doyle DJH, J.M.; Garmon, E.H. Society of Anesthesiologists Classification: StatPearls Publishing LLC; 2023.

Jammer I, Wickboldt N, Sander M, Smith A, Schultz MJ, Pelosi P, et al. Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol. 2015;32(2):88–105.

Article  PubMed  Google Scholar 

Low DE, Alderson D, Cecconello I, Chang AC, Darling GE, D’Journo XB, et al. International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg. 2015;262(2):286–94.

Article  PubMed  Google Scholar 

Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.

Article  PubMed  PubMed Central  Google Scholar 

Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al (2017) The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin, 67(2):93

Roukos D, Schmidt-Mathiesen A, Encke A. Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long-term survival analysis with emphasis on Lauren classification. Surg Oncol. 1995;4(6):323–32.

Article  CAS  PubMed  Google Scholar 

Arer IM, Yabanoglu H, Akdur A, Akkapulu N, Kus M. Total versus subtotal gastrectomy for signet ring cell carcinoma of the stomach. J Coll Physicians Surg Pak. 2017;27(10):616–20.

PubMed  Google Scholar 

Gajardo JA, Arriagada FJ, Muñoz FD, Veloso FA, Pacheco FA, Molina HE, et al. Subtotal versus total gastrectomy for distal diffuse-type gastric cancer. Surg Endosc. 2024;38(12):7588–95.

Article  PubMed  Google Scholar 

Honoré C, Goéré D, Messager M, Souadka A, Dumont F, Piessen G, et al. Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study. Eur J Surg Oncol. 2013;39(3):235–41.

Article  PubMed  Google Scholar 

Nilsson M. Postgastrectomy follow-up in the West: evidence base, guidelines, and daily practice. Gastric Cancer. 2017;20(Suppl 1):135–40.

Article  PubMed  Google Scholar 

Rino Y, Oshima T, Yoshikawa T. Changes in fat-soluble vitamin levels after gastrectomy for gastric cancer. Surg Today. 2017;47(2):145–50.

Article  CAS  PubMed  Google Scholar 

Jiang N, Deng JY, Ding XW, Zhang L, Liu HG, Liang YX. Effect of complication grade on survival following curative gastrectomy for carcinoma. World J Gastroenterol. 2014;20(25):8244–52.